A scoping review in the European Journal of Cancer reveals key evidence gaps in patient perspectives regarding generative AI safety, equity, and governance in oncology.
Most Recent Articles
Subclinical Leaflet Thrombosis Reductions With NOAC Monotherapy Following TAVI Procedures
The ACASA-TAVI trial published in JAMA shows NOAC monotherapy significantly reduces post-TAVI bioprosthetic leaflet thrombosis without increasing bleeding risks compared to aspirin.
AI-Enabled Focused Cardiac Ultrasound: Expanding Screening Access for Moderate to Severe AS
A JAMA Cardiology study demonstrates that AI-guided heart ultrasound acquired by novice operators enables accurate screening for moderate or severe aortic stenosis.
Mitochondrial Aco2 Inhibition and Citrate Export Drive Epigenetic Adaptations in Mitohormesis
Salk Institute researchers revealed that mitochondrial citrate acts as a second messenger in mitohormetic signaling, protecting the adult heart against doxorubicin toxicity.
Clopidogrel Monotherapy Versus Extended DAPT in High-Ischemic-Risk Stent Patients: The A-CLOSE Trial
The A-CLOSE trial published in NEJM shows extended DAPT reduces major ischemic events, whereas clopidogrel monotherapy lowers bleeding in high-risk post-stent patients.
